Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Treatment of Patients With Takayasu Arteritis Complicated With Pulmonary Artery Involvement

NCT: NCT05388682 · RECRUITING

NCT IDNCT05388682
StatusRECRUITING
Start Date2014-01-19
Completion2042-12-31
SponsorChinese Pulmonary Vascular Disease Research Group (OTHER)
First posted
Last updated

Brief Summary

1. Evaluate the effect of medical treatment and percutaneous transluminal pulmonary angioplasty on takayasu arteritis with pulmonary artery involvement 2. evaluate the efficacy of FAPI in predicting the activity and treatment efficacy of takayasu arteritis with pulmonary artery involvement

Frequently Asked Questions

What is Treatment of Patients With Takayasu Arteritis Complicated With Pulmonary Artery Involvement?

Treatment of Patients With Takayasu Arteritis Complicated With Pulmonary Artery Involvement is a clinical trial registered under NCT05388682. Current status: RECRUITING.

What is the status of NCT05388682?

The current status of NCT05388682 (Treatment of Patients With Takayasu Arteritis Complicated With Pulmonary Artery Involvement) is: RECRUITING.

When did Treatment of Patients With Takayasu Arteritis Complicated With Pulmonary Artery Involvement start?

Treatment of Patients With Takayasu Arteritis Complicated With Pulmonary Artery Involvement started on 2014-01-19.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.